2020 Ophthalmology Deals, By Number of Selling Doctors
We looked at completed ophthalmology deals in 2020 to understand different practice sizes that transacted. A couple of items are of note -
We saw a fairly even distribution of small vs. medium deals, with fewer "large" deals, as expected. Most private equity firms have acquired their large platforms and are now filling-in with small and medium "add-on" transactions.
Around half of the selling groups were represented by an investment banking firm, with most of the unrepresented groups being small.
The size breakdown is shown below:
To learn more download our latest ophthalmology industry report entitled ...
"After a Strong First Quarter, 2021 Is Now Looking Like a True Window of Opportunity for Ophthalmology Deals"
This post is for informational purposes only and does not constitute an offer, invitation, solicitation, or recommendation to buy, sell, subscribe for, or issue any securities. While the information provided herein is believed to be accurate and reliable, 127 Capital, LLC (“Physicians First”) makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.